Hideyuki Tozaki

909 total citations
15 papers, 742 citations indexed

About

Hideyuki Tozaki is a scholar working on Pharmaceutical Science, Surgery and Genetics. According to data from OpenAlex, Hideyuki Tozaki has authored 15 papers receiving a total of 742 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmaceutical Science, 6 papers in Surgery and 5 papers in Genetics. Recurrent topics in Hideyuki Tozaki's work include Advanced Drug Delivery Systems (8 papers), Inflammatory Bowel Disease (5 papers) and Drug Solubulity and Delivery Systems (5 papers). Hideyuki Tozaki is often cited by papers focused on Advanced Drug Delivery Systems (8 papers), Inflammatory Bowel Disease (5 papers) and Drug Solubulity and Delivery Systems (5 papers). Hideyuki Tozaki collaborates with scholars based in Japan and United States. Hideyuki Tozaki's co-authors include Shozo Muranishi, Akira Yamamoto, Akira Terabe, Tsutomu Suzuki, Takuya Fujita, Junta Komoike, Susumu Okabe, Chika Tada, Takako Maruyama and Naoki Okada and has published in prestigious journals such as Journal of Controlled Release, Life Sciences and Journal of Pharmaceutical Sciences.

In The Last Decade

Hideyuki Tozaki

15 papers receiving 700 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hideyuki Tozaki Japan	11	490	145	118	111	99	15	742
Akira Terabe Japan	6	348 0.7×	74 0.5×	142 1.2×	82 0.7×	70 0.7×	8	550
Cao De-ying China	13	292 0.6×	254 1.8×	169 1.4×	33 0.3×	66 0.7×	29	655
Junta Komoike Japan	3	244 0.5×	48 0.3×	57 0.5×	52 0.5×	48 0.5×	5	336
C.M. Savariar Malaysia	5	221 0.5×	95 0.7×	54 0.5×	53 0.5×	46 0.5×	7	436
Supandeep Singh Hallan Italy	14	347 0.7×	203 1.4×	126 1.1×	13 0.1×	113 1.1×	20	690
Betty Philip Oman	5	210 0.4×	45 0.3×	61 0.5×	42 0.4×	38 0.4×	10	364
Xiulan Pu China	8	96 0.2×	189 1.3×	74 0.6×	25 0.2×	45 0.5×	11	468
Mónica Rosa Ireland	11	255 0.5×	190 1.3×	44 0.4×	16 0.1×	43 0.4×	15	520
Naijing Ye China	11	107 0.2×	152 1.0×	107 0.9×	16 0.1×	50 0.5×	17	590
Meisi Lin China	7	99 0.2×	128 0.9×	79 0.7×	16 0.1×	46 0.5×	12	388

Countries citing papers authored by Hideyuki Tozaki

Since Specialization

Citations

This map shows the geographic impact of Hideyuki Tozaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideyuki Tozaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideyuki Tozaki more than expected).

Fields of papers citing papers by Hideyuki Tozaki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideyuki Tozaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideyuki Tozaki. The network helps show where Hideyuki Tozaki may publish in the future.

Co-authorship network of co-authors of Hideyuki Tozaki

This figure shows the co-authorship network connecting the top 25 collaborators of Hideyuki Tozaki. A scholar is included among the top collaborators of Hideyuki Tozaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideyuki Tozaki. Hideyuki Tozaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Tozaki, Hideyuki, Naoki Okada, Takuya Fujita, et al.. (2002). Chitosan capsules for colon-specific drug delivery: enhanced localization of 5-aminosalicylic acid in the large intestine accelerates healing of TNBS-induced colitis in rats. Journal of Controlled Release. 82(1). 51–61. 154 indexed citations

Tozaki, Hideyuki, Junko Nishioka, Junta Komoike, et al.. (2001). Enhanced Absorption of Insulin and (Asu1,7)Eel‐Calcitonin using Novel Azopolymer‐Coated Pellets for Colon‐Specific Drug Delivery. Journal of Pharmaceutical Sciences. 90(1). 89–97. 47 indexed citations

Tozaki, Hideyuki, Junko Nishioka, Junta Komoike, et al.. (2001). Enhanced absorption of insulin and (Asu1,7)eel‐calcitonin using novel azopolymer‐coated pellets for colon‐specific drug delivery. Journal of Pharmaceutical Sciences. 90(1). 89–97. 2 indexed citations

Sakai, I., Hideyuki Tozaki, Yukiko Ito, et al.. (1999). Development of an Oral Formulation of Azetirelin, a New Thyrotropin-Releasing Hormone (TRH) Analogue, Using n-Lauryl-.BETA.-D-maltopyranoside as an Absorption Enhacer.. Biological and Pharmaceutical Bulletin. 22(6). 611–615. 12 indexed citations

Tozaki, Hideyuki, Takuya Fujita, Akira Terabe, et al.. (1999). Colon-specific delivery of R68070, a new thromboxane synthase inhibitor, using chitosan capsules: Therapeutic effects against 2,4,6-trinitrobenzene sulfonic acid-induced ulcerative colitis in rats. Life Sciences. 64(13). 1155–1162. 45 indexed citations

Tozaki, Hideyuki, Takuya Fujita, Junta Komoike, et al.. (1999). Colon-specific Delivery of Budesonide with Azopolymer-coated Pellets: Therapeutic Effects of Budesonide with a Novel Dosage Form against 2,4,6-Trinitrobenzenesulphonic Acid-induced Colitis in Rats. Journal of Pharmacy and Pharmacology. 51(3). 257–261. 33 indexed citations

Tozaki, Hideyuki, Takuya Fujita, Akira Terabe, et al.. (1999). Validation of a Pharmacokinetic Model of Colon-specific Drug Delivery and the Therapeutic Effects of Chitosan Capsules Containing 5-Aminosalicylic Acid on 2,4,6-Trinitrobenzenesulphonic Acid-induced Colitis in Rats. Journal of Pharmacy and Pharmacology. 51(10). 1107–1112. 38 indexed citations

Tozaki, Hideyuki, Takuya Fujita, Masahiro Murakami, et al.. (1998). Colon delivery of anti-inflammatory drugs accelerates healing of TNBS induced-colitis in rats.. Drug Delivery System. 13(3). 165–171. 5 indexed citations

Tozaki, Hideyuki, Toshio Taniguchi, Takuya Fujita, et al.. (1998). Use of Protease Inhibitors to Improve Calcitonin Absorption from the Small and Large Intestine in Rats. Journal of Pharmacy and Pharmacology. 50(8). 913–920. 36 indexed citations

10.

Tozaki, Hideyuki, Akira Yamamoto, & Shozo Muranishi. (1997). Chitosan capsules for colon-specific drug delivery: Improvement of insulin absorption from the rat colon.. Drug Delivery System. 12(5). 311–320. 11 indexed citations

11.

Tozaki, Hideyuki, et al.. (1997). Degradation of Insulin and Calcitonin and Their Protection by Various Protease Inhibitors in Rat Caecal Contents: Implications in Peptide Delivery to the Colon. Journal of Pharmacy and Pharmacology. 49(2). 164–168. 69 indexed citations

12.

Tozaki, Hideyuki, Junta Komoike, Chika Tada, et al.. (1997). Chitosan Capsules for Colon-Specific Drug Delivery: Improvement of Insulin Absorption from the Rat Colon. Journal of Pharmaceutical Sciences. 86(9). 1016–1021. 254 indexed citations

13.

Tozaki, Hideyuki, Toshio Taniguchi, Akira Yamamoto, & Shozo Muranishi. (1996). Intestinal Absorption of Insulin in the Absence of Intestinal-fluid Enzymes. Pharmacy and Pharmacology Communications. 2(8). 365–368. 6 indexed citations

14.

Tozaki, Hideyuki, Takuya Fujita, Akira Yamamoto, et al.. (1996). Chitosan capsules for colon-specific drug delivery: Improvement of insulin absorption from the rat colon.. Drug Delivery System. 11(2). 119–124. 8 indexed citations

15.

Tozaki, Hideyuki, et al.. (1995). Metabolism of peptide drugs by the microorganisms in rat cecal contents.. Biological and Pharmaceutical Bulletin. 18(6). 929–931. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact